Tourmaline Bio, Inc.
TRML · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$73,210 | -$42,124 | -$19,701 | -$47,833 |
| Dep. & Amort. | $39 | $33 | $6 | $623 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6,593 | $5,769 | $195 | $0 |
| Change in WC | -$3,154 | -$168 | $902 | $2,315 |
| Other Non-Cash | -$7,531 | $8,409 | $12,140 | $4,907 |
| Operating Cash Flow | -$77,263 | -$28,081 | -$6,458 | -$39,988 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9 | -$56 | -$68 | -$2,437 |
| Net Acquisitions | $0 | $0 | -$5,000 | $0 |
| Inv. Purchases | -$366,136 | -$16,604 | $0 | -$275,879 |
| Inv. Sales/Matur. | $171,840 | $20,500 | $0 | $181,929 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$194,305 | $3,840 | -$5,068 | -$96,387 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$150 | $0 |
| Stock Issued | $161,352 | $70,468 | $20,000 | $137,677 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$4 | $86,252 | $20,000 | -$277 |
| Financing Cash Flow | $161,348 | $156,720 | $19,850 | $137,400 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$110,220 | $132,479 | $8,324 | $1,025 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $140,953 | $8,474 | $150 | $17,589 |
| End Cash | $30,733 | $140,953 | $8,474 | $18,614 |
| Free Cash Flow | -$77,272 | -$28,137 | -$11,526 | -$42,425 |